Age-Based Differences in the Genetic Determinants of Glycemic Control: A Case of FOXO3 Variations
- PMID: 25993007
- PMCID: PMC4439071
- DOI: 10.1371/journal.pone.0126696
Age-Based Differences in the Genetic Determinants of Glycemic Control: A Case of FOXO3 Variations
Abstract
Background: Glucose homeostasis is a trait of healthy ageing and is crucial to the elderly, but less consideration has been given to the age composition in most studies involving genetics and hyperglycemia.
Methods: Seven variants in FOXO3 were genotyped in three cohorts (n = 2037; LLI, MI_S and MI_N; mean age: 92.5 ± 3.6, 45.9 ± 8.2 and 46.8 ± 10.3, respectively) to compare the contribution of FOXO3 to fasting hyperglycemia (FH) between long-lived individuals (LLI, aged over 90 years) and middle-aged subjects (aged from 35-65 years).
Results: A different genetic predisposition of FOXO3 alleles to FH was observed between LLI and both of two middle-aged cohorts. In the LLI cohort, the longevity beneficial alleles of three variants with the haplotype "AGGC" in block 1 were significantly protective to FH, fasting glucose, hemoglobin A1C and HOMA-IR. Notably, combining multifactor dimensionality reduction and logistic regression, we identified a significant 3-factor interaction model (rs2802288, rs2802292 and moderate physical activity) associated with lower FH risk. However, not all of the findings were replicated in the two middle-aged cohorts.
Conclusion: Our data provides a novel insight into the inconsistent genetic determinants between middle-aged and LLI subjects. FOXO3 might act as a shared genetic predisposition to hyperglycemia and lifespan.
Conflict of interest statement
Figures



References
-
- Schmidt MI, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski A. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes care. 1981;4(6):579–85. Epub 1981/11/01. . - PubMed
-
- Rodriguez BL, Curb JD, Burchfiel CM, Huang B, Sharp DS, Lu GY, et al. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Diabetes care. 1996;19(6):587–90. Epub 1996/06/01. . - PubMed
-
- National Center for Chronic Disease Prevention and Health Promotion C. Chronic disease notes and reports: special focus. Healthy Aging. 1999;12(3).
-
- Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes care. 2000;23(1):45–50. Epub 2000/06/17. . - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous